|
⚲
|
| Keyboard |
| Davidson Michael H
✚
|
|
|---|---|
| CIK # | 0001573785 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001573785] | |
| 4 | [0001573785] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Davidson Michael H | |
| BioAge Labs Inc | |
| NewAmsterdam Pharma Co NV | |
| Tenax Therapeutics Inc | |
| Silence Therapeutics PLC | |
| Lisata Therapeutics Inc | |
| Omthera Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-02 | Sell | 443,707 | $33.25 | 14,753,258 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-02 | Option exercise | 443,707 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-03-02 | Option exercise | 443,707 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-26 | Sell | 17,924 | $34.44 | 617,303 |
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-02-26 | Option exercise | 183,332 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-26 | Sell | 165,408 | $33.63 | 5,562,671 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-26 | Option exercise | 183,332 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-25 | Sell | 10,436 | $35.96 | 375,279 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-25 | Option exercise | 58,253 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-02-25 | Option exercise | 58,253 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-25 | Sell | 1,300 | $36.68 | 47,684 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-25 | Sell | 46,517 | $35.11 | 1,633,212 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-24 | Sell | 61,547 | $36.13 | 2,223,693 |
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-02-24 | Option exercise | 64,708 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-24 | Sell | 3,161 | $36.46 | 115,250 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-24 | Option exercise | 64,708 | ||
|
Tenax Therapeutics Inc TENX
Stock Option (right to buy) · derivative
|
2026-01-09 | Grant | 30,000 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-07 | Sell | 11,582 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-07 | Grant | 81,000 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-01-07 | Grant | 364,000 | $0.00 | |
| showing 20 of 52 most recent transactions | |||||